Protocols · Metabolic
Lipo-C dosage protocol
Dosage and protocol information sourced exclusively from PeptideDosages.com.
Read this first
Dosage and protocol figures on this page are reproduced only from the matching PeptideDosages.com protocol. The 3 ml table is arithmetic based on those source amounts and the listed vial sizes. Educational research only — not instructions or medical advice.
Dosage protocol
PeptideDosages.com does not currently publish a matching protocol for Lipo-C. No dosage, schedule, reconstitution figure, or syringe-unit calculation is shown on this page.
Check the source protocol indexOther metabolic compounds
Lipo-C: research background
What 'Lipo-C' compounds are in these studies
In the provided research, 'Lipo-C' does not refer to a single standardized compound, but rather to various liposomal or lipopeptide formulations, often containing a 'C' component (e.g., carboplatin, control, or a specific lipopeptide branch). For instance, one study describes ICG-Lipo-C&D as a liposomal formulation encapsulating carboplatin and docetaxel for photodynamic therapy (PMID 35700912). Another refers to 'lipo C' as a control liposome without transferrin (PMID 15911226) or a specific branched lipopeptide in rabies vaccine research (PMID 27182006). A different study utilized 'lipo c ADM = Ab' as Adriamycin-encapsulated and CA19-9 antibody-conjugated liposomes (PMID 7610458). Finally, 'Pro-Lipo C' denotes a food-grade proliposome preparation used for encapsulating EDTA (PMID 27780298).
How 'Lipo-C' formulations are thought to work
The mechanisms depend on the specific formulation. ICG-Lipo-C&D, for example, functions as a nanoscale drug delivery system for chemotherapeutic photodynamic therapy, utilizing the enhanced permeability retention effect to deliver photosensitizers and encapsulated drugs (carboplatin and docetaxel) to tumor tissues (animal study, PMID 35700912). Transferrin-tagged liposomes (lipo Tf) are designed to target the blood-brain barrier via receptor-mediated endocytosis, potentially for delivering protein or peptide drugs, although intracellular degradation was observed (cell study, PMID 15911226). Antibody-conjugated liposomes ('lipo c ADM = Ab') aim for targeted chemotherapy by enhancing tumor accessibility and drug delivery (cell and animal studies, PMID 7610458). The branched lipopeptide 'Lipo C' in rabies research stimulates the maturation of dendritic cells and promotes T cell responses to improve vaccine efficacy (cell study, PMID 27182006). Pro-Lipo C encapsulates EDTA to assess its effects in cheese-making (food product study, PMID 27780298).
What laboratory and animal studies report
In an animal study, chemo-PDT using ICG-Lipo-C&D in a murine colon 26 CDF1 mouse model showed a stronger antitumor effect than ICG-Lipo alone, increasing immune-related gene expression and decreasing cytoskeleton-related gene expression in tumor tissues (PMID 35700912). Another animal study with human pancreatic cancer cells (PK-1) implanted in mice demonstrated that antibody-conjugated liposomes ('lipo c ADM = Ab') resulted in higher intra-tumor Adriamycin concentration and a significant inhibitory effect on tumor growth compared to free Adriamycin (animal and cell study, PMID 7610458). In a cell study, transferrin-tagged liposomes (lipo Tf) showed two- to three-fold higher association with brain capillary endothelial cells than control liposomes (lipo C), indicating targeting to the blood-brain barrier in vitro (cell study, PMID 15911226). In rabies vaccine research, the branched lipopeptide 'Lipo C' stimulated stronger phenotypic and functional maturation of dendritic cells and more efficient CD8(+) T cell responses in vitro, and also assisted rabies vaccine to induce instant rabies virus neutralizing antibody production and better protection against rabies virus challenge at an early stage (cell study, PMID 27182006).
Key terms explained
<b>Liposomes:</b> Tiny spherical vesicles made of a lipid bilayer, similar to cell membranes, used to encapsulate and deliver substances.
<b>Photodynamic Therapy (PDT):</b> A medical treatment that uses light to activate a photosensitizing agent, which then kills nearby cells.
<b>Enhanced Permeability Retention (EPR) Effect:</b> A phenomenon where certain molecules (like liposomes) tend to accumulate in tumor tissue more than in normal tissue, due to the tumor's leaky vasculature and impaired lymphatic drainage.
<b>Lipotropic Blend (MIC):</b> This specific term is not explicitly defined or used in the provided abstracts, where 'Lipo C' refers to various liposomal or lipopeptide formulations.
Studies cited in this section
- Inhibitory effects and gene expression analysis of chemotherapeutic photodynamic therapy by using a liposomally formulated indocyanine green derivative. — Photodiagnosis and photodynamic therapy, 2022 (PMID 35700912)
- Targeting liposomes with protein drugs to the blood-brain barrier in vitro. — European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2005 (PMID 15911226)
- Targeting chemotherapy using antibody-combined liposome against human pancreatic cancer cell-line. — The Tohoku journal of experimental medicine, 1995 (PMID 7610458)
- A novel rabies virus lipopeptide provides a better protection by improving the magnitude of DCs activation and T cell responses. — Virus research, 2016 (PMID 27182006)
- Manufacture and Incorporation of Liposome-Entrapped Ethylenediaminetetraacetic Acid into Model Miniature Gouda-Type Cheese and Subsequent Effect on Starter Viability, pH, and Moisture Content. — Journal of food science, 2016 (PMID 27780298)
Summarised from the PubMed abstracts listed above. Educational reference only — not medical advice or instructions.
Nearby in the protocol A–Z
Peptide Intel Hub is an independent publication and has no affiliation, ownership or commercial relationship with the suppliers listed. We sell nothing and take no payments — links are editorial references only.